首页 | 官方网站   微博 | 高级检索  
     

DDP,5Fu/CF加干扰素治疗晚期鼻咽癌的初步报告
引用本文:黄慧强,李宇红.DDP,5Fu/CF加干扰素治疗晚期鼻咽癌的初步报告[J].癌症,1998,17(6):450-452.
作者姓名:黄慧强  李宇红
作者单位:中山医科大学肿瘤医院内科
摘    要:目的:评价DDP+5Fu/CF+IN(干扰素)方案治疗晚期鼻咽癌的疗效和毒性反应。方法:本文采用DDP+5Fu/CF=INF(DDP20mg/m^2×5,5Fu300mg-400mg/m^2×5,INF3×10^6U×3)方案共治疗晚期鼻咽癌26例;结果:25例可评价儿,总有效率(CR+PR)80%(20/25),CR率12%,中位缓解期4.8月(2-12月)。在放疗和/七化疗后复发转移的21例中

关 键 词:鼻咽肿瘤  醛氢叶酸  干扰素  药物疗法

Preliminary result of DDP,5 Fu and High dose Leucovorin (HDCF)Plus Interferon (INF) for the treatment of Advanced or ReccurentNasopharyngeal Carcinoma (NPC)
Huang Huiqiang,Li YuHong,He Youjian.Preliminary result of DDP,5 Fu and High dose Leucovorin (HDCF)Plus Interferon (INF) for the treatment of Advanced or ReccurentNasopharyngeal Carcinoma (NPC)[J].Chinese Journal of Cancer,1998,17(6):450-452.
Authors:Huang Huiqiang  Li YuHong  He Youjian
Affiliation:Huang Huiqiang Li YuHong He YoujianDepartment of Medical Oncology,Cancer Center,Sun Yat sen University of Medical Sciences,Guang zhou 510060
Abstract:Purpose:To assess the safety and efficacy of DDP +5 Fu/HDCF+INF combination (double biochemical modulation of 5 Fu) in the treatment of advanced and reccurent nasopharygeal carcinoma (AR NPC).Methods:26 patients with AR NPC were treated by DDP +5 Fu/HDCF+INF regimen.Results:25 patients were evaluable for objetive response.The total response rate was 80% with CR rate of 12%.The response rate (RR) was 76.2% for the patients previously treated by radiotherapy and chemotherapy while RR was 81.8% for the patients previously treated with DDP/ THP +5 Fu/HDCF.The major toxicity included leucopenia,mucositis,vomiting nausea and diarrhea with percentage of grade 3 and 4 toxicity (WHO) being 22%,23.7%,10.1% and 11.9%,respectively.Conclusions:DDP+5 Fu/HDCF+INF is an effective combination in the chemotherapy of AR NPC,as well as close attention should be paid to its toxicity.
Keywords:Nasopharyngeal Neoplasm  Interferon/therapeutic use  Leucovorin/therapeutic use  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号